Adma Biologics (ADMA) Other Non Operating Income (2013 - 2025)
Adma Biologics (ADMA) posted Other Non Operating Income of $2.1 million for Q4 2025, up 9995.24% on a QoQ basis from -$21000.0 in Q3 2025, and up 2516.28% year-over-year from $79425.8 in Q4 2024.
Adma Biologics (ADMA) Other Non Operating Income (2013 - 2025) Analysis & Trends
Adma Biologics' Other Non Operating Income history runs 9 years deep, the most recent figure standing at $2.1 million for Q4 2025.
- Quarterly Other Non Operating Income rose 2516.28% year-over-year to $2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $834000.0 (up 532.12% YoY) and the FY2025 annual result came in at $1.9 million, up 1075.65% from the prior year.
- Other Non Operating Income was $2.1 million for Q4 2025 at Adma Biologics, up from -$21000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $2.1 million in Q4 2025 and bottomed at -$1.2 million in Q2 2025.
- A 5-year average of -$28525.2 and a median of -$45500.0 in 2024 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 2516.28% in 2025, while the deepest fall reached 7143.75% in 2025.
- Adma Biologics' Other Non Operating Income stood at -$252000.0 in 2021, then tumbled by 74.23% to -$439058.0 in 2022, then soared by 77.0% to -$101000.0 in 2023, then climbed by 14.85% to -$86000.0 in 2024, then jumped by 2516.28% to $2.1 million in 2025.
- Business Quant data shows ADMA's Other Non Operating Income at $2.1 million in Q4 2025, -$21000.0 in Q3 2025, and -$1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.08 Mn |
| Sep 30, 2025 | -21,000.00 |
| Jun 30, 2025 | -1.16 Mn |
| Mar 31, 2025 | -64,000.00 |
| Dec 31, 2024 | -86,000.00 |
| Sep 30, 2024 | -56,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Dec 31, 2023 | -101,000.00 |
| Sep 30, 2023 | -145,000.00 |
| Jun 30, 2023 | -13,000.00 |
| Mar 31, 2023 | -27,000.00 |
| Dec 31, 2022 | -439,058.00 |
| Sep 30, 2022 | -9,641.00 |
| Jun 30, 2022 | -19,421.00 |
| Mar 31, 2022 | -166,880.00 |
| Dec 31, 2021 | -252,000.00 |
| Sep 30, 2021 | 18,546.00 |
| Dec 31, 2020 | 1.03 Mn |
| Sep 30, 2020 | -26,440.00 |